V-ATPase inhibition increases cancer cell stiffness and blocks membrane related Ras signaling - a new option for HCC therapy.
about
Endolysosomal Cation Channels and Cancer-A Link with Great Potential.Statistics for real-time deformability cytometry: Clustering, dimensionality reduction, and significance testing.The vacuolar-type ATPase inhibitor archazolid increases tumor cell adhesion to endothelial cells by accumulating extracellular collagen
P2860
V-ATPase inhibition increases cancer cell stiffness and blocks membrane related Ras signaling - a new option for HCC therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
V-ATPase inhibition increases ...... a new option for HCC therapy.
@en
V-ATPase inhibition increases ...... a new option for HCC therapy.
@nl
type
label
V-ATPase inhibition increases ...... a new option for HCC therapy.
@en
V-ATPase inhibition increases ...... a new option for HCC therapy.
@nl
prefLabel
V-ATPase inhibition increases ...... a new option for HCC therapy.
@en
V-ATPase inhibition increases ...... a new option for HCC therapy.
@nl
P2093
P2860
P50
P356
P1433
P1476
V-ATPase inhibition increases ...... a new option for HCC therapy.
@en
P2093
Angelika M Vollmar
Dirk Menche
Karin Bartel
Karin von Schwarzenberg
Maria Winzi
Melanie Ulrich
Rolf Müller
P2860
P304
P356
10.18632/ONCOTARGET.14339
P407
P577
2016-12-28T00:00:00Z